Meloxicam Beapy Bluemed Unipessoal, Lda (Meloxicam)

Meloxicam works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which reduces the production of prostaglandins—chemical mediators that cause inflammation, pain, and fever. This selective inhibition helps control symptoms while sparing the protective COX‑1 activity in the stomach.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for meloxicam during pregnancy and lactation are limited. It is generally advised to avoid use unless clearly needed and prescribed by a qualified clinician, as potential risks to the fetus or infant cannot be ruled out.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam has a longer half‑life and greater selectivity for COX‑2 compared with ibuprofen, which may allow once‑daily dosing and potentially lower gastrointestinal risk. However, individual response varies, and clinicians consider patient history, comorbidities and drug‑interaction profiles when choosing an NSAID.

Meloxicam should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Meloxicam is administered orally, usually as a tablet or capsule, and should be taken with a full glass of water. It can be taken with or without food, but taking it with food may reduce stomach upset.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe liver injury, and life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice signs such as black stools, chest pain, sudden jaundice, or severe rash.

Meloxicam is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe heart failure, and patients who have had a recent coronary artery bypass graft. It should also be used with caution in patients with renal or hepatic impairment.